Blueshift Asset Management, LLC Bausch Health Companies Inc. Transaction History

Blueshift Asset Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$7.06 - $23.63 $689,882 - $2.31 Million	97,717 Added 481.46%	118,013 $987,000
Q1 2022 May 12, 2022	BUY	$21.6 - $27.79 $438,393 - $564,025	20,296 New	20,296 $464,000
Q1 2021 May 06, 2021	SELL	$21.37 - $34.38 $382,352 - $615,126	-17,892 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$15.31 - $21.12 $273,926 - $377,879	17,892 New	17,892 $372,000
Q1 2020 May 14, 2020	SELL	$12.98 - $30.25 $366,412 - $853,927	-28,229 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$18.89 - $31.89 $225,697 - $381,021	11,948 Added 73.39%	28,229 $845,000
Q3 2019 Nov 12, 2019	BUY	$20.88 - $25.66 $339,947 - $417,770	16,281 New	16,281 $356,000

254

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.67B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Blueshift Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Blueshift Asset Management, LLC with notifications on news.